US Stem Cell Inc (USRM)

[Dragon Lady]

MASSIVE DILUTION- and it was said there would be "none to little" in a previous post.

The number of shares outstanding of the registrant’s Common Stock, $0.001 par value, as of March 24, 2014 was 420,920,157.

From the last 10-Q to today was about 347 MILLION shares to now 420 MILLION which I stated near to the mark in previous posts. Spot on correct to what I estimate from the trend.

Cash and cash equivalents on balance sheet: $46,227.00 total dollars. Yep, over 60 MILLION shares dumped, and all that's left is $46K cash on the books.

"We have also initiated the MIRROR trial, which is a Phase III, double-blind placebo controlled study for centers outside the US. The SEISMIC, MYOHEART,MARVEL and MIRROR Trials have been designed to test the safety and efficacy of MyoCell in treating patients with severe, chronic damage to the heart. Upon regulatory approval of MyoCell, we intend to generate revenue in the United States from the sale of MyoCell cell-culturing services for treatment of patients by qualified physicians."
THAT IS IT- when I did a search on "Mirror"- pretty much a GOOSE EGG NOTHING comes up. WOW !! I'll verify with a cover to cover read- but the search feature usually doesn't miss much? Wow, is all I can say.

I'll read the rest of the report in detail- but it's par for the course so far IMO. A typical BHRT 10-Q/10-K. Massive dilution, almost no cash left, and little to show for it. I'm going to look for every "deal" announced and other key info. Will post later after I get time to read every line.

I'll link to the post that said "no dilution".